| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial
|
Dei-Cas, Eduardo
|
|
1998
|
22 |
1-2 |
p. 1-4
4 p.
|
artikel
|
| 2 |
I. Genetic heterogeneity in Pneumocystis carinii: an introduction
|
Wakefield, Ann E.
|
|
1998
|
22 |
1-2 |
p. 5-13
9 p.
|
artikel
|
| 3 |
III. Typing methods to approach Pneumocystis carinii genetic heterogeneity
|
Hauser, Philippe M
|
|
1998
|
22 |
1-2 |
p. 27-35
9 p.
|
artikel
|
| 4 |
II. The genome of Pneumocystis carinii
|
Stringer, James R.
|
|
1998
|
22 |
1-2 |
p. 15-26
12 p.
|
artikel
|
| 5 |
IV. Potential impact of Pneumocystis genetic diversity on the molecular detection of the parasite in human host
|
Tamburrini, Enrica
|
|
1998
|
22 |
1-2 |
p. 37-49
13 p.
|
artikel
|
| 6 |
IX. Pneumocystis: the `carrrier state': epidemiology and transmission of human pneumocystosis
|
Latouche, Sophie
|
|
1998
|
22 |
1-2 |
p. 81-86
6 p.
|
artikel
|
| 7 |
V. Genetic heterogeneity of rat-derived Pneumocystis
|
Cushion, Melanie T.
|
|
1998
|
22 |
1-2 |
p. 51-58
8 p.
|
artikel
|
| 8 |
VI. Genetic heterogeneity in human-derived Pneumocystis carinii
|
Wakefield, Ann E
|
|
1998
|
22 |
1-2 |
p. 59-65
7 p.
|
artikel
|
| 9 |
VIII. Epidemiological and taxonomic impact of Pneumocystis biodiversity
|
Mazars, Edith
|
|
1998
|
22 |
1-2 |
p. 75-80
6 p.
|
artikel
|
| 10 |
VII. The major surface antigen of Pneumocystis carinii
|
Nakamura, Yoshikazu
|
|
1998
|
22 |
1-2 |
p. 67-74
8 p.
|
artikel
|
| 11 |
XI. Emerging aspects related to the application of biomolecular techniques to the diagnosis of Pneumocystis carinii pneumonia: our experience with ITSs primers
|
Atzori, C
|
|
1998
|
22 |
1-2 |
p. 93-95
3 p.
|
artikel
|
| 12 |
XIII. Clinical aspects of Pneumocystis carinii pneumonia in HIV-infected patients: 1997
|
Miller, Robert
|
|
1998
|
22 |
1-2 |
p. 103-105
3 p.
|
artikel
|
| 13 |
XII. PCR for detecting Pneumocystis carinii in clinical or environmental samples
|
Lundgren, Bettina
|
|
1998
|
22 |
1-2 |
p. 97-101
5 p.
|
artikel
|
| 14 |
XIV. Response to Pneumocystis infection in an immunocompetent host
|
Rajagopalan-Levasseur, Préma
|
|
1998
|
22 |
1-2 |
p. 107-121
15 p.
|
artikel
|
| 15 |
XIX. A transphyletic anti-infectious control strategy based on the killer phenomenon
|
Conti, Stefania
|
|
1998
|
22 |
1-2 |
p. 151-161
11 p.
|
artikel
|
| 16 |
X. Pneumocystis and pneumocystosis in Europe at the end of the 20th century
|
Roux, P
|
|
1998
|
22 |
1-2 |
p. 87-91
5 p.
|
artikel
|
| 17 |
XVIII. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis
|
Séguy, Nathalie
|
|
1998
|
22 |
1-2 |
p. 145-149
5 p.
|
artikel
|
| 18 |
XVII. Lipid metabolism of Pneumocystis: toward the definition of new molecular targets
|
Kaneshiro, Edna S
|
|
1998
|
22 |
1-2 |
p. 135-143
9 p.
|
artikel
|
| 19 |
XVI. The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis
|
Benfield, Thomas L.
|
|
1998
|
22 |
1-2 |
p. 129-134
6 p.
|
artikel
|
| 20 |
XV. Pneumocystosis pathophysiology
|
Prévost, Marie-Claude
|
|
1998
|
22 |
1-2 |
p. 123-128
6 p.
|
artikel
|
| 21 |
XX. Animal models of pneumocystosis
|
Dei-Cas, Eduardo
|
|
1998
|
22 |
1-2 |
p. 163-168
6 p.
|
artikel
|
| 22 |
XXI. Current in vitro culture systems for Pneumocystis
|
Atzori, Chiara
|
|
1998
|
22 |
1-2 |
p. 169-172
4 p.
|
artikel
|
| 23 |
XXII. Evaluation of drug efficacy by using animal models or in vitro systems
|
Brun Pascaud, Monique
|
|
1998
|
22 |
1-2 |
p. 173-179
7 p.
|
artikel
|
| 24 |
XXIII. In vitro drug assays and statistical analysis
|
Atzori, Chiara
|
|
1998
|
22 |
1-2 |
p. 181-183
3 p.
|
artikel
|
| 25 |
XXIV. Morphological and ultrastructural methods for Pneumocystis
|
Dei-Cas, Eduardo
|
|
1998
|
22 |
1-2 |
p. 185-189
5 p.
|
artikel
|
Tijdschrift beschrijving